Through analyzing a reported GWAS dataset [16], we identified 2 variants in the human MAP7D1 gene significantly associated with decline of cardiac function and heart failure in cancer patients who received the doxorubicin chemotherapy. This evidence concerns the gene MAP7D1 and cancer.